Clinical Trial Update: A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 study evaluated a five-drug regimen (gemcitabine, nab-paclitaxel, capecitabine, cisplatin, and irinotecan) in metastatic pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Camptosar (irinotecan)
• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Adenocarcinoma, Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-08